![]() |
市場調査レポート
商品コード
1800962
気道陽圧装置の市場レポート:製品タイプ、エンドユーザー、地域別、2025年~2033年Positive Airway Pressure Devices Market Report by Product Type (Automatic Positive Airway Pressure Devices, Continuous Positive Airway Pressure Devices, Bi-level Positive Airway Pressure Devices), End User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
気道陽圧装置の市場レポート:製品タイプ、エンドユーザー、地域別、2025年~2033年 |
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2~3営業日
|
世界の気道陽圧装置市場規模は2024年に38億米ドルに達しました。今後、IMARC Groupは、2033年には61億米ドルに達し、2025年~2033年の成長率(CAGR)は5.14%になると予測しています。うつ病、高血圧、糖尿病、心臓疾患の増加が市場を刺激しています。
睡眠時無呼吸症候群の有病率の増加
睡眠障害の発生に対する意識の高まりは、診断と治療に対する需要をエスカレートさせており、これが市場を活性化しています。例えば、オランダのヘルスケア企業Philipsは2024年5月、睡眠時無呼吸症候群の治療に使用される持続陽圧呼吸療法(CPAP)装置を発売しました。さらにインドでは、フィリップスがホットラインやウェブサイトを通じてサポートを提供しています。これが気道陽圧装置市場の展望に寄与しています。
技術的進歩の高まり
治療効果の向上、ユーザーのニーズに応じた圧力レベルの自動調整、患者の快適性の向上など、絶え間ない技術革新が市場を刺激しています。さらに、騒音を最小限に抑えることを目的とした機能を備えたマスクデザインの進歩も、市場全体を後押ししています。2024年7月、酸素濃縮器ソリューションで知られていたVaron社は、睡眠時無呼吸症候群患者に効果的で快適な治療を提供し、医師の処方設定や治療計画と統合する新しいSunnygrandシリーズを発表しました。また、ヘルスケア専門家による継続的なモニタリングや調整にも対応しています。気道陽圧装置市場分析レポートによると、これは重要な成長促進要因として作用しています。
在宅ヘルスケアへの需要の高まり
ヘルスケアコストの高騰と患者中心のケアの重視の高まりにより、睡眠時無呼吸症候群の在宅管理を選択する個人が増加しています。これにより、ヘルスケアプロバイダーは遠隔で治療をモニターし、調整することができます。2024年3月、リアクト・ヘルス社は、ルナTravelPAPと呼ばれる旅行用CPAPを開発しました。これはCPAPとAutoCPAPモードを備えた小型軽量の気道陽圧装置です。さらに、供給リマインダー、オプションのキャリングケース、ライトリング・インジケータなどを備えています。
The global positive airway pressure devices market size reached USD 3.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.14% during 2025-2033. The increasing occurrence of depression, hypertension, diabetes, and heart disorders is stimulating the market.
Increasing Prevalence of Sleep Apnea
The rising awareness towards the occurrence of sleep disorders is escalating the demand for diagnosis and treatment, which is catalyzing the market. For example, in May 2024, Dutch healthcare company Philips launched continuous positive airway pressure (CPAP) therapy devices that are used to treat sleep apnea. Moreover, in India, Philips offered support through a hotline and website. This is contributing to the positive airway pressure devices market outlook.
Rising Technological Advancements
Continuous innovations, which enhance treatment efficacy, automatically adjust pressure levels based on the user's needs, elevate patient comfort, etc., are stimulating the market. Furthermore, advances in mask design with features aimed at minimizing noise are also propelling the overall market. In July 2024, Varon, previously known for oxygen concentrator solutions, introduced its new Sunnygrand series that offer effective and comfortable treatment for sleep apnea patients, integrating with doctors' prescribed settings and therapy plans. It also supports ongoing monitoring and adjustments by healthcare professionals. As per the positive airway pressure devices market analysis report, it is acting as a significant growth-inducing factor.
Escalating Demand for Home Healthcare
With the inflating healthcare costs and the increasing emphasis on patient-centric care, more individuals are opting for home-based management of sleep apnea. It allows healthcare providers to monitor and adjust treatment remotely. In March 2024, React Health developed a travel CPAP called the Luna TravelPAP. It is a small, lightweight positive airway pressure device with CPAP and AutoCPAP modes. Additionally, it has supply reminders, an optional carrying case, a light ring indicator, etc.
Continuous positive airway pressure (CPAP) devices dominate the total positive airway pressure devices market share
The inflating requirement for enhanced user comfort and treatment efficacy is driving the segment's growth. For example, the development of ResMed's AirSense 11, which features an auto-adjusting algorithm and integrated connectivity that enables personalized therapy adjustments and remote monitoring.
Hospitals and sleep labs hold the majority of the global positive airway pressure devices market demand
In these clinical settings, advanced PAP devices are utilized to ensure accurate diagnosis and effective treatment. For example, the Philips Respironics DreamStation BiPAP AutoSV is frequently adopted in hospitals for patients with complex sleep apnea, owing to its ability to adjust pressure levels automatically based on the patient's needs. This is expanding the positive airway pressure devices market forecast report.
North America exhibits a clear dominance in the market
The positive airway pressure devices market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The widespread prevalence of sleep apnea and other respiratory disorders is augmenting the positive airway pressure devices market outlook report in North America. In February 2024, ResMed introduced its AirCurve 11 series bilevel positive airway pressure devices in the U.S. It is designed to help providers treat sleep apnea while patients start and stay on therapy.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include: